|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lung Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Carcinoma, Non-Small-Cell Lung | |||||
| Lung Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| Lung Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Respiratory Tract Diseases | |||||
| Respiratory Tract Neoplasms | |||||
| Thoracic Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| cisplatin | |||||
| docetaxel | |||||
| conventional surgery | |||||
| neoadjuvant therapy | |||||
| radiation therapy | |||||
| 5 | Sponsors listed in this trial | ||||
| Swiss Group for Clinical Cancer Research | |||||